BlackRock, Inc. 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-07 12:29 pm Sale |
2024-02-29 | 13G | Alpine Immune Sciences, Inc. ALPN |
BlackRock Inc. BLK |
3,026,330 4.600% |
-32,168 (-1.05%) |
Filing |
| 2024-02-02 3:57 pm Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
BlackRock Inc. BLK |
3,058,498 5.300% |
3,058,498 (New Position) |
Filing |